VKTX Viking Therapeutics, Inc. logo

VKTX Viking Therapeutics, Inc.

Healthcare
$30.80-0.29%ClosedMarket Cap: $3.58B

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

22

Dispositions

14

Buy/Sell Ratio

1.57

Net Shares

+744,372

Shares Acquired

1,125,103

Shares Disposed

380,731

Total Bought ($)

$1.00

Total Sold ($)

$13.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 10Aubuchon Neil Williamofficer: Chief Commercial OfficerBuy4,475$33.504,475
Mon Jan 26Aubuchon Neil Williamofficer: Chief Commercial OfficerSell180,000$31.76180,000
Mon Jan 26Aubuchon Neil WilliamSell0$0.000
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell31,961$32.30215,571
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell13,900$33.38201,671
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell10,300$34.24191,371
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell1,500$32.09189,891
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell91,000$35.4291,000
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell41,000$0.00215,483
Mon Jan 05ZANTE GREGofficer: Chief Financial OfficerSell32,049$0.00247,532